Selective serotonin 5-HT(1A) receptor biased agonists elicitdistinct brain activation patterns: a pharmacoMRI study

od Becker, G., Bolbos, R., Costes, N., Redouté, J., Newman-Tancredi, A., Zimmer, L.
Izdano u Sci Rep (2016)

Steric control of CO binding in a totally synthetic heme protein model

od Busch, Daryle H., Zimmer, L. Lawrence, Grzybowski, Joseph J., Olszanski, Dennis J., Jackels, Susan C., Callahan, Robert C., Christoph, Gary G.
Izdano 1981

Paclitaxel with or without trametinib or pazopanib in advanced wild-type BRAF melanoma (PACMEL): a multicentre, open-label, randomised, controlled phase II trial

od Urbonas, V, Schadendorf, D, Zimmer, L, Danson, S, Marshall, E, Corrie, P, Wheater, M, Plummer, E, Mauch, C, Scudder, C, Goff, M, Love, S B, Mohammed, S B, Middleton, M R
Izdano u Ann Oncol (2019)

TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours

od Griewank, K G, Murali, R, Schilling, B, Scholz, S, Sucker, A, Song, M, Süsskind, D, Grabellus, F, Zimmer, L, Hillen, U, Steuhl, K-P, Schadendorf, D, Westekemper, H, Zeschnigk, M
Izdano 2013

Quantitative longitudinal imaging of activated microglia as a marker of inflammation in the pilocarpine rat model of epilepsy using [(11)C]-(R)-PK11195 PET and MRI

od Yankam Njiwa, J, Costes, N, Bouillot, C, Bouvard, S, Fieux, S, Becker, G, Levigoureux, E, Kocevar, G, Stamile, C, Langlois, JB, Bolbos, R, Bonnet, C, Bezin, L, Zimmer, L, Hammers, A
Izdano u J Cereb Blood Flow Metab (2016)

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients

od Dold, L., Zimmer, L., Schwarze-Zander, C., Boesecke, C., Mohr, R., Wasmuth, J.-C., Ommer, K., Gathof, B., Krämer, B., Nattermann, J., Strassburg, C. P., Rockstroh, J. K., Spengler, U., Langhans, B.
Izdano u J Mol Med (Berl) (2020)

Secondary preventive medication persistence and adherence 1 year after stroke

od Bushnell, C.D., Olson, D.M., Zhao, X., Pan, W., Zimmer, L.O., Goldstein, L.B., Alberts, M.J., Fagan, S.C., Fonarow, G.C., Johnston, S.C., Kidwell, C., LaBresh, K.A., Ovbiagele, B., Schwamm, L., Peterson, E.D.
Izdano 2011

Differential influence of vemurafenib and dabrafenib on patients’ lymphocytes despite similar clinical efficacy in melanoma

od Schilling, B., Sondermann, W., Zhao, F., Griewank, K. G., Livingstone, E., Sucker, A., Zelba, H., Weide, B., Trefzer, U., Wilhelm, T., Loquai, C., Berking, C., Hassel, J., Kähler, K. C., Utikal, J., Al Ghazal, P., Gutzmer, R., Goldinger, S. M., Zimmer, L., Paschen, A., Hillen, U., Schadendorf, D.
Izdano u Ann Oncol (2014)